Business
Eli Lilly hikes sales outlook, as CEO says there's room for 'dramatic' obesity market expansion
Eli Lilly reported that sales of obesity drug Zepbound and diabetes treatment Mounjaro surged again in the third quarter.
Advertisement
Topic
Lilly
Entertainment
‘Lilly,’ Starring Patricia Clarkson, to Open London’s Women and the World Intl. Film Festival
Rachel Feldman’s “Lilly,” starring Patricia Clarkson, will open the third edition of the Women and the World International Film Festival, which runs in London from Nov. 5-12. Highlights of the program, which puts women’s authorship at its center, include the world premiere of Sigrid Andrea P. Bernardo’s “Laya,” alongside premieres of Marina Kunarova’s “The Nomad’s […]
Business
Walmart to cover some GLP-1s, inhalers and insulin for employees at no cost as it expands benefits
Walmart will offer Novo's Ozempic and Lilly's Mounjaro without charge for people with Type 2 diabetes after a new prior authorization.
World
Obesity: the weight of prejudice in a chronic and complex disease
Obesity continues to be surrounded by simplistic ideas that reduce it to a question of image or will force.'Grounds of weight ', the initiative promoted by the medical company Lilly brings together specialists from different fields to dismount these prejudices and remember that it is a complex and progressive disease that has been simplified for years and that requires a comprehensive approach, adapted to each person
Business
Why Lilly and Novo are betting on amylin to power a new wave of obesity drugs after GLP-1s
Eli Lilly and Novo are developing new amylin drugs that serve as another biological lever to pull in treating obesity and diabetes.
Business
Wall Street is closing out a strong quarter. Plus, Lilly's mixed obesity drug trial data
Every weekday, the Investing Club releases the Homestretch; an actionable afternoon update just in time for the last hour of trading.
Business
Eli Lilly says closely watched combo obesity regimen boosts weight loss in mid-stage trial
Lilly said it plans to start Phase 3 trials on the combo regimen adding its amylin drug eloralintide to tirzepatide at the end of the year.
Business
Novo is betting on its next chapter as Eli Lilly gains more ground in GLP-1s
As Novo works to turn itself around, some analysts say Lilly has advantages that could help it maintain its position at the top of the obesity drug market.
Advertisement
Business
Eli Lilly CEO tells CNBC one-third of new GLP-1 pill patients are taking Foundayo, as drugmaker ramps up production
Eli Lilly is trying to catch up in the GLP-1 pill market to Novo, which got a head start in the space.
Business
Eli Lilly CEO says 700,000 new seniors have started GLP-1s after Medicare coverage, and 70% are on Lilly drugs
They're the latest metrics on how much the new Medicare coverage is expanding access to GLP-1 medicines since it launched in July.